Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

NCT03759522 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Fibromyalgia
Chronic Fatigue Syndrome
Multiple Sclerosis
Healthy

Interventions

DRUG: DPA-714 PET/MRI

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]